Cargando…

NK-92 cells retain vitality and functionality when grown in standard cell culture conditions

NK-92 cells are an off-the-shelf, cell-based immunotherapy currently in clinical trials for a variety of cancer types. As the most ‘NK-like’ cell line available, it is also an important research tool. To date, NK-92 cells have been cultivated in a costly and time-consumingly prepared specialized med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotzur, Rebecca, Duev-Cohen, Alexandra, Kol, Inbal, Reches, Adi, Mandelboim, Ofer, Stein, Natan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926178/ https://www.ncbi.nlm.nih.gov/pubmed/35294457 http://dx.doi.org/10.1371/journal.pone.0264897

Ejemplares similares

IFNG-AS1 Enhances Interferon Gamma Production in Human Natural Killer Cells
por: Stein, Natan, et al.
Publicado: (2019)

PILRα binds an unknown receptor expressed primarily on CD56(bright) and decidual-NK cells and activates NK cell functions
por: Ophir, Yael, et al.
Publicado: (2016)

NK Cells Under Hypoxia: The Two Faces of Vascularization in Tumor and Pregnancy
por: Garcés-Lázaro, Irene, et al.
Publicado: (2022)

Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST
por: Kotzur, Rebecca, et al.
Publicado: (2023)

Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity
por: Reches, Adi, et al.
Publicado: (2020)

The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity
por: Duev-Cohen, Alexandra, et al.
Publicado: (2016)

A Unique Regulation Region in the 3′ UTR of HLA-G with a Promising Potential
por: Reches, Adi, et al.
Publicado: (2020)

Candida albicans evades NK cell elimination via binding of Agglutinin-Like Sequence proteins to the checkpoint receptor TIGIT
por: Charpak-Amikam, Yoav, et al.
Publicado: (2022)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
por: Panwong, Suthida, et al.
Publicado: (2021)

Altered NKp46 Recognition and Elimination of Influenza B Viruses
por: Duev-Cohen, Alexandra, et al.
Publicado: (2020)

Anti-RhD antibody therapy modulates human natural killer cell function
por: Elias, Shlomo, et al.
Publicado: (2020)

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)
por: Elias, Shlomo, et al.
Publicado: (2018)

Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression
por: Glasner, Ariella, et al.
Publicado: (2017)

CD100 on NK Cells Enhance IFNγ Secretion and Killing of Target Cells Expressing CD72
por: Mizrahi, Sa'ar, et al.
Publicado: (2007)

Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA*008 to Escape Elimination by NK Cells
por: Seidel, Einat, et al.
Publicado: (2015)

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
por: Romanski, Annette, et al.
Publicado: (2016)

Limited response of NK92 cells to Plasmodium falciparum-infected erythrocytes
por: de Carvalho, Elisandra Grangeiro, et al.
Publicado: (2011)

Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
por: Yang, Chaopin, et al.
Publicado: (2019)

Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
por: Podshivalova, Elizaveta Sergeevna, et al.
Publicado: (2021)

P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells
por: Klingemann, H
Publicado: (2014)

NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease
por: Ghadially, Hormas, et al.
Publicado: (2014)

Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D
por: Diab, Mohammad, et al.
Publicado: (2020)

Targeting T-cell malignancies using anti-CD4 CAR NK-92 cells
por: Pinz, Kevin G., et al.
Publicado: (2017)

Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells
por: Tian, Xiaopeng, et al.
Publicado: (2023)

Corrigendum: Focused Ultrasound Improves NK-92MI Cells Infiltration Into Tumors
por: Yang, Chaopin, et al.
Publicado: (2019)

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells
por: Chrobok, Michael, et al.
Publicado: (2019)

Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer
por: Cao, Bihui, et al.
Publicado: (2021)

Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern
por: Chaouat, Abigael E., et al.
Publicado: (2022)

CAR NK-92 cell–mediated depletion of residual TCR(+) cells for ultrapure allogeneic TCR-deleted CAR T-cell products
por: Kath, Jonas, et al.
Publicado: (2023)

Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma
por: Zhang, Qing, et al.
Publicado: (2017)

HSV-2 Specifically Down Regulates HLA-C Expression to Render HSV-2-Infected DCs Susceptible to NK Cell Killing
por: Elboim, Moran, et al.
Publicado: (2013)

Detection of Active Granzyme A in NK92 Cells with Fluorescent Activity-Based Probe
por: Kołt, Sonia, et al.
Publicado: (2020)

Natural Killer Cell Line NK-92-Mediated Damage of Medically Important Fungi
por: Schmidt, Stanislaw, et al.
Publicado: (2021)

Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
por: Montagner, Isabella Monia, et al.
Publicado: (2020)

When 19 is greater than 92
por: Zeitels, Lauren R, et al.
Publicado: (2013)

Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease
por: Stiglund, Natalie, et al.
Publicado: (2019)

Leptin affects filopodia and cofilin in NK-92 cells in a dose- and time-dependent manner
por: Oswald, Jana, et al.
Publicado: (2018)

Endurance Exercise Diverts the Balance between Th17 Cells and Regulatory T Cells
por: Perry, Chava, et al.
Publicado: (2013)

Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
por: Zhang, Jianguang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h22ifomi1ap9ei9mhfqm8dmkk8